The first Prometheus Biosciences trade was made in Q1 2021.
Since then Ken Griffin bought shares three more times and sold shares on five occasions. The investor completely sold their stake between Q1 2023 and Q2 2023.
Avg closing price
Price range
Sold -47.1 Thousand shares
Q2 2023
Avg closing price
$181.30
Price range
$108.58
-
$199.92
Sold 19.2% shares (-11.2 Thousand shares)
Q1 2023
Avg closing price
$115.10
Price range
$103.46
-
$126.29
New holding (+58.3 Thousand shares)
Q4 2022
Avg closing price
$64.85
Price range
$36.06
-
$117.21
Sold -648 Thousand shares
Q3 2022
Avg closing price
$45.76
Price range
$28.17
-
$59.01
Increased shares by 4628.8% (+634 Thousand shares)
Q2 2022